You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 17, 2025

Drug Price Trends for NDC 70677-0163


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 70677-0163

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 70677-0163

Last updated: January 4, 2025

Understanding the National Drug Code (NDC)

To analyze the market and project prices for a drug identified by the NDC 70677-0163, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that serves as a universal product identifier for human drugs in the United States. It identifies the labeler, product, and trade package size of the drug[4].

NDC Structure

The NDC 70677-0163 can be broken down into three segments:

  • Labeler Code: The first segment (70677) is assigned by the FDA and identifies the firm that manufactures, repacks, or relabels the drug.
  • Product Code: The second segment identifies a specific strength, dosage form, and formulation for the particular firm.
  • Package Code: The third segment identifies the package sizes and types[4].

Market Context

Drug Listings and Compliance

The drug with NDC 70677-0163 must be listed in the FDA's National Drug Code Directory, which includes information on active and certified finished and unfinished drugs submitted by labelers. This directory is updated daily and contains product listing data for all finished drugs, including prescription and over-the-counter drugs, approved and unapproved drugs, and repackaged and relabeled drugs[1].

Pricing Mechanisms

For drugs participating in programs like the Medicaid Drug Rebate Program (MDRP), prices are calculated based on the Average Manufacturer Price (AMP) and the Unit Rebate Amount (URA). The 340B ceiling price, for example, is calculated by subtracting the URA from the AMP and then adjusting for package size and case pack size[2].

Price Trends and Projections

Historical Price Data

To project future prices, historical price data is essential. For instance, the median price increase for brand name drugs was 13.4% in 2022, which can serve as a benchmark for future price adjustments[5].

Specific Drug Pricing

For the drug NDC 70677-0163, one would need to look at historical pricing data. Here is an example of how pricing can be analyzed using a similar drug:

Drug Name NDC Price/Unit ($) Date
Example Drug 00378-2245 0.66780 2024-12-18
Example Drug 00378-2245 0.64236 2024-11-20
Example Drug 00378-2245 0.54917 2024-10-23
Example Drug 00378-2245 0.50016 2024-09-18

This example shows a declining trend in price per unit over the specified period. If similar data is available for NDC 70677-0163, it would help in projecting future prices.

Market Analysis

Market Share and Competition

The market share and competitive landscape play significant roles in price projections. For instance, a study on non-traditional pharmaceutical models showed that these models can produce drugs in volumes comparable to traditional models, but with varying price dynamics. The prices of drugs sold by non-traditional models can be significantly different from those of traditional models, sometimes being cheaper or more expensive depending on the market and product mix[3].

Regulatory Impact

Regulatory changes and compliance requirements can also impact pricing. For example, outsourcing facilities that compound human drug products may choose to assign NDCs to their products, which can affect pricing transparency and competition in the market[1].

Key Factors Influencing Price Projections

Average Manufacturer Price (AMP) and Unit Rebate Amount (URA)

Changes in AMP and URA directly affect the ceiling prices for drugs, especially those participating in programs like the 340B program[2].

Market Demand and Supply

Fluctuations in demand and supply can significantly impact drug prices. An increase in demand or a shortage in supply can drive prices up, while an oversupply or reduced demand can lead to price decreases.

Regulatory Changes

Changes in FDA regulations, such as updates to the NDC Directory or new requirements for drug establishments, can influence pricing strategies and market dynamics.

Economic Conditions

General economic conditions, including inflation and healthcare policy changes, can also impact drug prices.

Price Projection Methodology

To project prices for NDC 70677-0163, the following steps can be taken:

  1. Collect Historical Data: Gather historical pricing data for the drug to identify trends.
  2. Analyze Market Dynamics: Examine market share, competition, and regulatory changes.
  3. Calculate AMP and URA: If applicable, calculate the Average Manufacturer Price and Unit Rebate Amount to determine the ceiling price.
  4. Adjust for Economic Factors: Consider general economic conditions and healthcare policy changes.
  5. Forecast Future Prices: Use statistical models or trend analysis to forecast future prices based on the collected data.

Example Projection

Assuming a similar declining trend as in the example provided, if the price per unit for NDC 70677-0163 was $1.00 in the previous quarter, a 10% decrease per quarter could be projected based on historical data.

Quarter Price/Unit ($)
Current 1.00
Next Quarter 0.90
Following Quarter 0.81

This is a simplified example and actual projections would require more detailed and specific data.

Key Takeaways

  • NDC Structure: The NDC is a three-segment number identifying the labeler, product, and package size.
  • Market Listings: The drug must be listed in the FDA's NDC Directory.
  • Pricing Mechanisms: Prices are influenced by AMP, URA, and regulatory programs.
  • Historical Data: Essential for identifying trends and projecting future prices.
  • Market Dynamics: Market share, competition, and regulatory changes impact prices.
  • Economic Factors: General economic conditions and healthcare policies also influence prices.

FAQs

Q: What is the National Drug Code (NDC)? A: The NDC is a unique, three-segment number that identifies the labeler, product, and trade package size of a drug.

Q: How is the 340B ceiling price calculated? A: The 340B ceiling price is calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) and then adjusting for package size and case pack size.

Q: Why are some drug products not included in the NDC Directory? A: Drug products may not be included if they are not prescription drugs, OTC drugs, or insulin products, or if the firm has not complied with listing obligations.

Q: How do regulatory changes affect drug prices? A: Regulatory changes can impact pricing by altering the requirements for drug establishments, affecting market transparency, and influencing competition.

Q: What factors should be considered when projecting drug prices? A: Historical pricing data, market dynamics, regulatory changes, and economic conditions should all be considered when projecting drug prices.

Sources

  1. FDA's National Drug Code Directory - FDA
  2. NDC Product Details - HRSA
  3. SDP Nonprofit Quantitative Issue Brief - ASPE
  4. National Drug Code Database Background Information - FDA
  5. Latest drug prices and trends for NDC 00378-2245 - DrugPatentWatch

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.